Barclays logo

Institution

Barclays Research Reports & Analysis

Finvaulta tracks 126 research reports on Barclays, updated through August 26, 2026. Latest: “Climate Tech: Five Topics Shaping Investor Discussions”.

Barclays research maintains a multi-faceted approach, balancing specific equity selections with broader thematic shifts across global markets. Analysts are currently emphasizing a rotation toward Value within European equities, citing that Momentum is losing steam and Quality lacks fundamental support amid hawkish ECB policy. Stock-specific conviction remains high in pockets of the biotech sector, notably with an Overweight rating on C4 Therapeutics, while the firm remains cautious on Apple's near-term AI integration due to monetization uncertainties. Beyond corporate analysis, the research underscores significant macroeconomic trends, including the impact of JPY weakness driven by shifting Japanese household asset allocations and retail FX positioning. These reports collectively highlight a focus on execution risks, sector-specific consolidation, and the navigation of inflationary headwinds through disciplined, factor-based investment strategies.

Featured reports

Climate Tech: Five Topics Shaping Investor Discussions thumbnail

Climate Tech: Five Topics Shaping Investor Discussions

Barclays·Aug 26, 2026

Barclays synthesizes key investor discussions following its Climate Tech deep-dive, highlighting 17 prioritized technologies across 37 analyzed. The note argues that Climate Tech is evolving into a critical infrastructure and adaptation theme rather than solely a decarbonisation play.

European Morning Research Summary thumbnail

European Morning Research Summary

Barclays·Jun 30, 2026

This report provides a daily summary of Barclays Equity Research in Europe, covering updates across various sectors including basic industries, consumer goods, healthcare, and industrials.

Americas Morning Research Summary thumbnail

Americas Morning Research Summary

Barclays·Jun 22, 2026

The Barclays Americas Morning Research Summary for June 22, 2026, highlights a market tempered by hawkish FOMC rhetoric and geopolitical tensions in the Middle East, alongside sector-specific updates for metals, banking, and pharmaceuticals.

Americas Small Cap Research Summary thumbnail

Americas Small Cap Research Summary

Barclays·Jun 18, 2026

This Barclays research summary covers C4 Therapeutics, assigning it an 'Overweight' rating with a focus on its Cemsidomide development in multiple myeloma.

Apple Another AI Attempt At WWDC thumbnail

Apple Another AI Attempt At WWDC

Barclays·Jun 9, 2026

Barclays maintains an Underweight rating on Apple following WWDC, viewing the new AI features as incremental and lacking clear monetization potential.

Italian Banks First Thoughts On M&A Scenarios thumbnail

Italian Banks First Thoughts On M&A Scenarios

Barclays·Jun 9, 2026

Barclays analyzes the recent M&A bids for MPS from Banco BPM and the Intesa SanPaolo-Unipol consortium. The report highlights the strategic implications and potential market shifts for the Italian banking sector.

Global Traders' Guide: Key Data and Events

Barclays·Aug 14, 2026

BoJ's Hawkish Summary Tips Our Next Hike Call into September

Barclays·Aug 14, 2026

Latin America Outlook: Growth Rebound Seems Hard to Sustain

Barclays·Aug 14, 2026

Sign up to access 120 more reports

All reports

Page 1 of 6

About Barclays

Visit Website

Recurring series

European Morning Research Summary

36 editions

Americas Small Cap Research Summary

30 editions

Americas Morning Research Summary

35 editions

Use in AI assistants

Search this research archive inside ChatGPT, Claude, or Perplexity.

ChatGPTClaudePerplexity

Related

Health CareEquitiesFinancialsLLYMacro Economic IndicatorsTSLA

Get full access

Create an account to follow this research